|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 417/12 | (2006.01) |
| C07D 417/14 | (2006.01) | ||
| A61K 31/433 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2209778 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08834504.6 |
| Date of filing the European patent application | 2008-09-15 | |
| (97) | Date of publication of the European application | 2010-07-28 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
| (46) | Date of publication of the claims translation | 2012-10-25 |
| (86) | Number | PCT/US2008/076401 |
| Date | 2008-09-15 |
| (87) | Number | WO 2009/042435 |
| Date | 2009-04-02 |
| (30) | Number | Date | Country code |
| 974225 P | 2007-09-21 | US |
| (72) |
AICHER, Thomas Daniel, US
BOYD, Steven Armen, US
CHICARELLI, Mark Joseph, US
CONDROSKI, Kevin Ronald, US
FELL, Jay Bradford, US
FISCHER, John P., US
GUNAWARDANA, Indrani W., US
HINKLIN, Ronald Jay, US
SINGH, Ajay, US
TURNER, Timothy M., US
WALLACE, Eli M., US
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Piridin-2 -il-amino-I,2,4 -tiadiazolio dariniai kaip gliukokinazės aktyvatoriai, skirti cukriniam diabetui gydyti |
| PYRIDIN-2 -YL-AMINO-I, 2, 4 -THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS |
| Payment date | Validity (years) | Amount | |
| 2017-08-18 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-09-15 |